UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 10-Q/A
Amendment No. 1
|
☒
|
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
For the Quarterly Period Ended March
31, 2017
|
☐
|
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
For the Transition Period from ______
to ______
Commission File Number: 333-153290
WEARABLE HEALTH SOLUTIONS, INC.
(Exact name of registrant as specified
in its charter)
|
Nevada
|
|
26-3534190
|
|
(State or other jurisdiction of incorporation or organization)
|
|
(I.R.S. Employer Identification No.)
|
|
|
|
|
|
200 W. Church Road Suite B, King of Prussia, PA
|
|
19406
|
|
(Address of principal executive offices)
|
|
(Zip Code)
|
|
|
(877) 639-2929
|
|
|
|
(Registrant’s telephone number, including area code)
|
|
|
|
|
|
|
|
N/A
|
|
|
|
(Former address)
|
|
Indicate
by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports),
and (2) has been subject to such filing requirements for the past 90 days. Yes
☐
No
☒
Indicate
by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive
Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the
preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes
☐
No
☒
Indicate by check
mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting
company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting
company” in Rule 12b-2 of the Exchange Act.
|
Large accelerated filer
|
☐
|
Accelerated filer
|
☐
|
|
Non-accelerated filer
|
☐
|
Smaller reporting company
|
☒
|
|
(Do not check if a smaller reporting company)
|
|
Emerging growth company
|
☐
|
Indicate by check
mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes
☐
No
☒
Indicate the number
of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.
|
Class
|
|
Outstanding at May 15, 2017
|
|
Common Stock, $0.0001 par value per share
|
|
49,874,177 shares
|
EXPLANATORY NOTE
The sole purpose of this Amendment
No. 1 to the registrant’s Quarterly Report on Form 10-Q which was filed with the Securities and Exchange Commission on May
22, 2017 for the quarter ended March 31, 2017 (the “Form 10-Q”), is to file Exhibits 101 to the Form 10-Q in accordance
with Rule 405 of Regulation S–T.
Except for the matters described
above, this Amendment No. 1 on Form 10-Q/A does not modify or update disclosures in, or exhibits to, the Form 10-Q. This Form
10-Q/A speaks as of the original filing date and does not reflect events that may have occurred subsequent to the original filing
date.
_____________________________________________________
(1) Filed as an exhibit to this Report.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
|
May 23, 2017
|
WEARABLE HEALTH SOLUTIONS, INC.
|
|
|
|
|
|
|
By:
|
/s/ Ronnie Adams
|
|
|
|
Ronnie Adams
Chief Executive Officer and
Chief Financial Officer
(Principal Executive Officer and
Principal Financial Officer and
Accounting Officer)
|